Amano M, Chihara K, Nakamura N, Kaneko T, Matsuura Y, Kaibuchi K
Division of Signal Transduction, Nara Institute of Science and Technology, 8916-5 Takayama, Ikoma 630-0101, Japan.
J Biol Chem. 1999 Nov 5;274(45):32418-24. doi: 10.1074/jbc.274.45.32418.
Rho-kinase is implicated in the phosphorylation of myosin light chain downstream of Rho, which is thought to induce smooth muscle contraction and stress fiber formation in non-muscle cells. Here, we examined the mode of action of inhibitors of Rho-kinase. The chemical compounds such as HA1077 and Y-32885 inhibited not only the Rho-kinase activity but also the activity of protein kinase N, one of the targets of Rho, but had less of an effect on the activity of myotonic dystrophy kinase-related Cdc42-binding kinase beta (MRCKbeta). The COOH-terminal portion of Rho-kinase containing Rho-binding (RB) and pleckstrin homology (PH) domains (RB/PH (TT)), in which point mutations were introduced to abolish the Rho binding activity, interacted with Rho-kinase and thereby inhibited the Rho-kinase activity, whereas RB/PH (TT) had no effect on the activity of protein kinase N or MRCKbeta, suggesting that the COOH-terminal region of Rho-kinase is a possible negative regulatory region of Rho-kinase. The expression of RB/PH (TT) specifically blocked the stress fiber and focal adhesion formation induced by the active form of Rho or Rho-kinase in NIH 3T3 cells, but not that induced by the active form of MRCKbeta or myosin light chain. Thus, RB/PH (TT) appears to specifically inhibit Rho-kinase in vivo.
Rho激酶与Rho下游的肌球蛋白轻链磷酸化有关,据认为它可诱导非肌肉细胞中的平滑肌收缩和应力纤维形成。在此,我们研究了Rho激酶抑制剂的作用方式。HA1077和Y-32885等化合物不仅抑制Rho激酶活性,还抑制Rho的靶标之一蛋白激酶N的活性,但对强直性肌营养不良激酶相关的Cdc42结合激酶β(MRCKβ)的活性影响较小。含有Rho结合(RB)和普列克底物蛋白同源(PH)结构域(RB/PH(TT))的Rho激酶COOH末端部分,其中引入了点突变以消除Rho结合活性,它与Rho激酶相互作用从而抑制Rho激酶活性,而RB/PH(TT)对蛋白激酶N或MRCKβ的活性没有影响,这表明Rho激酶的COOH末端区域可能是Rho激酶的负调控区域。RB/PH(TT)的表达特异性地阻断了NIH 3T3细胞中由活性形式的Rho或Rho激酶诱导的应力纤维和粘着斑形成,但不阻断由活性形式的MRCKβ或肌球蛋白轻链诱导的形成。因此,RB/PH(TT)似乎在体内特异性地抑制Rho激酶。